Article
Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Apr 2019
Fontana E, Eason K, Cervantes A, Salazar R, Sadanandam A
Abstract excerpt
The Colorectal Cancer Subtyping Consortium identified four gene expression consensus molecular subtypes, CMS1 (immune), CMS2 (canonical), CMS3 (metabolic), and CMS4 (mesenchymal), using multiple microarray or RNA-sequencing datasets of primary tumor samples mainly from early stage colon cancer patients. Consequently, rectal tumors and stage IV tumors (possibly reflective of more aggressive disease) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
